Michael Shy
Affiliations: | Wayne State University, Detroit, MI, United States |
Area:
Molecular BiologyGoogle:
"Michael Shy"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Touvier T, Veneri FA, Claessens A, et al. (2024) Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B. Biorxiv : the Preprint Server For Biology |
Sondheimer N, Aleman A, Cameron J, et al. (2023) Biallelic pathogenic variants in the mitochondrial form of phosphoenolpyruvate carboxykinase cause peripheral neuropathy. Hgg Advances. 4: 100182 |
Horvath R, Medina J, Reilly MM, et al. (2023) Peripheral neuropathy in mitochondrial disease. Handbook of Clinical Neurology. 194: 99-116 |
Bai Y, Treins C, Volpi VG, et al. (2022) Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice. Molecular Neurobiology |
Howard P, Feely SME, Grider T, et al. (2021) Loss of function MPZ mutation causes milder CMT1B neuropathy. Journal of the Peripheral Nervous System : Jpns |
Rebelo AP, Cortese A, Abraham A, et al. (2021) A CADM3 variant causes Charcot-Marie-Tooth disease with marked upper limb involvement. Brain : a Journal of Neurology |
Deng S, Feely SME, Shi Y, et al. (2019) Incidence and Clinical Features of TRPV4-Linked Axonal Neuropathies in a USA Cohort of Charcot-Marie-Tooth Disease Type 2. Neuromolecular Medicine |
Callegari I, Gemelli C, Geroldi A, et al. (2019) Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype. Journal of Neurology. 266: 2629-2645 |
Pareyson D, Stojkovic T, Reilly MM, et al. (2019) A multicentre retrospective study of Charcot-Marie-Tooth disease type 4B (CMT4B) due to mutations in Myotubularin-related proteins (MTMRs). Annals of Neurology |
Fratta P, Ornaghi F, Dati G, et al. (2018) A nonsense mutation in Myelin Protein Zero causes congenital hypomyelination neuropathy through altered P0 membrane targeting and gain of abnormal function. Human Molecular Genetics |